-
EP0475148
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0475148
| EP0475148 - Pravastatin alone or in combination with a fibric acid derivative for preventing onset of or treating type III hyperlipoproteinemia [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.03.1995 Database last updated on 02.11.2024 | Most recent event Tooltip | 20.03.1995 | Application deemed to be withdrawn | published on 10.05.1995 [1995/19] | Applicant(s) | For all designated states E.R. Squibb & Sons, Inc. P.O.Box 4000 Princeton New Jersey 08543-4000 / US | [N/P] |
| Former [1992/12] | For all designated states E.R. SQUIBB & SONS, INC. P.O.Box 4000 Princeton New Jersey 08543-4000 / US | Inventor(s) | 01 /
Pan, Henry Y. Dr. 7 Huntington Drive Princeton Junction, New Jersey 08550 / US | [1992/12] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [1992/12] | VOSSIUS & PARTNER Postfach 86 07 67 D-81634 München / DE | Application number, filing date | 91114074.7 | 22.08.1991 | [1992/12] | Priority number, date | US19900571685 | 23.08.1990 Original published format: US 571685 | [1992/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP0475148 | Date: | 18.03.1992 | Language: | EN | [1992/12] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 23.01.1992 | Classification | IPC: | A61K31/215, // (A61K31/215, 31:19) | [1992/12] | CPC: |
A61K31/22 (EP);
A61P3/06 (EP);
A61P9/10 (EP)
| C-Set: |
A61K31/22, A61K2300/00 (EP);
A61K31/22, A61K31/195, A61K31/19 (EP) | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, NL, SE [1992/12] | Title | German: | Pravastatin allein oder in Kombination mit einem Fibronsäurederivat zur Vorbeugung des Auftretens oder zur Behandlung von Hyperlipoproteinemia Typ-III | [1992/12] | English: | Pravastatin alone or in combination with a fibric acid derivative for preventing onset of or treating type III hyperlipoproteinemia | [1992/12] | French: | Pravastatine seule ou en combinaison avec un dérivé de l'acide fibrique pour prévenir l'apparition ou traiter l'hyperlipoprotéinémie de type III | [1992/12] | File destroyed: | 20.04.2002 | Examination procedure | 04.09.1992 | Examination requested [1992/45] | 20.06.1994 | Despatch of a communication from the examining division (Time limit: M04) | 01.11.1994 | Application deemed to be withdrawn, date of legal effect [1995/19] | 08.12.1994 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1995/19] | Fees paid | Renewal fee | 30.08.1993 | Renewal fee patent year 03 | 30.08.1994 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]EP0373507 (SQUIBB & SONS INC [US]) | [XD] - THE AMERICAN JOURNAL OF CARDIOLOGY, vol. 60, no. 12, 30th October 1987, pages 33G-43G; D.R. ILLINGWORTH et al: "Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia" | [X] - THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 319, no. 1, 7th July 1988, pages 24-33, The Massachusetts Medical Society; S.M. GRUNDY et al.: "HMG-CoA reductase inhibitors for treatment of hypercholesterolemia" | [YD] - DRUGS, vol. 36, supplement 3, 1988, pages 63-71, ADIS Press Ltd; D.R. ILLINGWORTH: "An overview of lipid-lowering drugs" | [YD] - METABOLISM, vol. 39, no. 4, April 1990, pages 403-409, W.B. Saunders Co. Harcourt Brace Jovanovich, Inc.; D.R. ILLINGWORTH et al.: "The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia" | [A] - THE JOURNAL OF JAPAN ATHEROSCLEROSIS SOCIETY, vol. 16, no. 1, 1988, pages 5-8; G. YOSHINO et al.: "Effect of CS-514 on type III and type III-like hyperlipoproteinemia" |